199 related articles for article (PubMed ID: 25266938)
21. Preoperative biliary drainage for malignant biliary obstruction: results from a national database.
Shaib Y; Rahal MA; Rammal MO; Mailhac A; Tamim H
J Hepatobiliary Pancreat Sci; 2017 Nov; 24(11):637-642. PubMed ID: 28902473
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of the relation between surgery and prognosis of hilar cholangiocarcinoma].
Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Cheng QB; Wu MC
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):842-5. PubMed ID: 16083598
[TBL] [Abstract][Full Text] [Related]
23. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
[TBL] [Abstract][Full Text] [Related]
24. Does long-term survival exist in pancreatic adenocarcinoma?
Zijlstra M; Bernards N; de Hingh IH; van de Wouw AJ; Goey SH; Jacobs EM; Lemmens VE; Creemers GJ
Acta Oncol; 2016; 55(3):259-64. PubMed ID: 26559995
[TBL] [Abstract][Full Text] [Related]
25. Preoperative biliary drainage adversely affects surgical outcomes in periampullary cancer: a retrospective and propensity score-matched analysis.
Lee H; Han Y; Kim JR; Kwon W; Kim SW; Jang JY
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):206-213. PubMed ID: 29222963
[TBL] [Abstract][Full Text] [Related]
26. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
[TBL] [Abstract][Full Text] [Related]
27. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
[TBL] [Abstract][Full Text] [Related]
28. Preoperative internal biliary drainage increases the risk of bile juice infection and pancreatic fistula after pancreatoduodenectomy: a prospective observational study.
Fujii T; Yamada S; Suenaga M; Kanda M; Takami H; Sugimoto H; Nomoto S; Nakao A; Kodera Y
Pancreas; 2015 Apr; 44(3):465-70. PubMed ID: 25423556
[TBL] [Abstract][Full Text] [Related]
29. Bridge of preoperative biliary drainage is a useful management for patients undergoing pancreaticoduodenectomy.
Endo Y; Noda H; Watanabe F; Kakizawa N; Fukui T; Kato T; Ichida K; Aizawa H; Kasahara N; Rikiyama T
Pancreatology; 2019 Jul; 19(5):775-780. PubMed ID: 31255445
[TBL] [Abstract][Full Text] [Related]
30. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
[TBL] [Abstract][Full Text] [Related]
31. Quality of survival in patients treated for malignant biliary obstruction caused by unresectable pancreatic head cancer: surgical versus non-surgical palliation.
Kim HO; Hwang SI; Kim H; Shin JH
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):643-8. PubMed ID: 19073412
[TBL] [Abstract][Full Text] [Related]
32. Significance of pathologic response to preoperative therapy in pancreatic cancer.
Chun YS; Cooper HS; Cohen SJ; Konski A; Burtness B; Denlinger CS; Astsaturov I; Hall MJ; Hoffman JP
Ann Surg Oncol; 2011 Dec; 18(13):3601-7. PubMed ID: 21947697
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.
Maire F; Hammel P; Ponsot P; Aubert A; O'Toole D; Hentic O; Levy P; Ruszniewski P
Am J Gastroenterol; 2006 Apr; 101(4):735-42. PubMed ID: 16635221
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of preoperative cholangitis after biliary drainage in patients who undergo pancreaticoduodenectomy on postoperative pancreatic fistula.
Yanagimoto H; Satoi S; Yamamoto T; Toyokawa H; Hirooka S; Yui R; Yamaki S; Ryota H; Inoue K; Michiura T; Matsui Y; Kwon AH
Am Surg; 2014 Jan; 80(1):36-42. PubMed ID: 24401513
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
Hata S; Sakamoto Y; Yamamoto Y; Nara S; Esaki M; Shimada K; Kosuge T
Ann Surg Oncol; 2012 Feb; 19(2):636-41. PubMed ID: 21863360
[TBL] [Abstract][Full Text] [Related]
36. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
37. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma.
Chen KT; Devarajan K; Hoffman JP
Ann Surg Oncol; 2015 Apr; 22(4):1185-9. PubMed ID: 25384699
[TBL] [Abstract][Full Text] [Related]
38. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
39. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.
Winter JM; Brennan MF; Tang LH; D'Angelica MI; Dematteo RP; Fong Y; Klimstra DS; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2012 Jan; 19(1):169-75. PubMed ID: 21761104
[TBL] [Abstract][Full Text] [Related]
40. Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma.
Fujiwara Y; Misawa T; Shiba H; Shirai Y; Iwase R; Haruki K; Furukawa K; Futagawa Y; Yanaga K
Anticancer Res; 2014 Sep; 34(9):5163-8. PubMed ID: 25202109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
